What do you do when you have in your hands the very first pill in the market to prevent HIV transmission? For us, the answer was to speak without prejudice.
We had the privilege to launch PrEP, targeting people at very high risk for HIV to dramatically reduce their chances of getting infected. Our client, Legacy Community Health gave us the opportunity. And we just took advantage of it.